93690-16-5 Usage
Uses
Used in Pharmaceutical Industry:
4-(3-methoxyphenyl)-1H-pyrazol-5-amine(SALTDATA: 1.1HCl) is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and potential pharmacological properties make it a candidate for the development of new drugs targeting specific biological pathways.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-(3-methoxyphenyl)-1H-pyrazol-5-amine(SALTDATA: 1.1HCl) serves as a valuable compound for studying the structure-activity relationships of drug molecules. Researchers can use 4-(3-methoxyphenyl)-1H-pyrazol-5-amine(SALTDATA: 1.1HCl) to investigate how modifications to its structure affect its biological activity and potential therapeutic applications.
Used in Drug Solubility Enhancement:
The hydrochloride salt form of 4-(3-methoxyphenyl)-1H-pyrazol-5-amine(SALTDATA: 1.1HCl) can be utilized to improve the solubility of the compound in various solvents. Enhanced solubility is crucial for drug development, as it can affect the compound's absorption, distribution, metabolism, and excretion, ultimately influencing its overall efficacy and safety.
Further research and testing are necessary to fully explore the potential uses and effects of 4-(3-methoxyphenyl)-1H-pyrazol-5-amine in its salt form, as well as to determine its suitability for specific applications in the pharmaceutical and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 93690-16-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,6,9 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 93690-16:
(7*9)+(6*3)+(5*6)+(4*9)+(3*0)+(2*1)+(1*6)=155
155 % 10 = 5
So 93690-16-5 is a valid CAS Registry Number.
93690-16-5Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
, (2012/11/08)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Reactivity of 7-(2-Dimethylaminovinyl)pyrazolopyrimidines: Synthesis of Pyrazolopyridopyrimidine Derivatives as Potential Benzodiazepine Receptor Ligands. 2.
Bruni, Fabrizio,Selleri, Silvia,Costanzo, Annarella,Guerrini, Gabriella,Casilli, Maria Lucia,Giusti, Laura
, p. 291 - 298 (2007/10/02)
A series of pyrazolopyridopyrimidin-6-ones was obtained by reaction of ammonium acetate with ethyl 7-dimethylaminovinylpyrazolopyrimidine-6-carboxylates and these had been prepared from ethyl 7-methylpyrazolopyrimidine-6-carboxylates by reaction with dimethylformamide dimethylacetat.Under these conditions the compounds bearing a 2-hydroxy group were also O-alkylated.During the preparation of the ethyl 2-hydroxy-7-methyl-3-phenylpyrazolopyrimidine-6-carboxylate the corresponding 5-methyl isomer was isolated and identified.
